Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Baofei
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Henan University of Chinese Medicine
- Administration
- Oral
01
Overview
Shenqi Baofei is a Traditional Chinese Medicine (TCM) formulation, typically administered as granules, developed by the First Affiliated Hospital of Henan University of Chinese Medicine. The formulation is designed to tonify Qi and supplement the lung, addressing conditions characterized by Lung and Spleen Qi deficiency. It is primarily composed of botanical extracts, including *Astragalus membranaceus* (Huangqi) and *Codonopsis pilosula* (Dangshen). In the context of the COVID-19 pandemic, Shenqi Baofei has been investigated in clinical trials to evaluate its efficacy in reducing re-hospitalization rates and improving the recovery of elderly patients following infection. Its therapeutic effects are attributed to its immunomodulatory and anti-inflammatory properties, which help restore respiratory function and overall vitality.
- Other names
- Shenqi Baofei GranulesShenqi Baofei Tang参芪补肺
02
Targets
IL-6 (Interleukin 6)VEGFA (Vascular endothelial growth factor A)BAX (Apoptosis regulator BAX)CASP3 (Caspase-3)JNK (Mitogen-activated protein kinase kinase kinase family)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)
Beyond the preview
Go deeper on Shenqi Baofei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenqi Baofei.